bf/NASDAQ:ELEV_icon.jpeg

COM:ELEVATIONONCOLOGY

Elevation Oncology, Inc.

  • Stock

Last Close

0.67

12/11 21:00

Market Cap

144.25M

Beta: -

Volume Today

632.28K

Avg: -

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-...Show More

peer of